Day: September 20, 2022

QPR SOFTWARE PLC                           INSIDE INFORMATION                   20 September 2022 AT 10 AMOn September 20, 2022, QPR Software Plc issued a negotiation proposal in accordance with the Act on Co-operation within Undertakings to start change negotiations to adapt its operations in order to improve the profitability of the business and enhance the implementation of the company’s strategy. According to preliminary estimates, the plans that may be implemented after the change negotiations could lead to personnel layoffs and the termination of a maximum of 25 jobs. The scope of the negotiations includes the company’s entire personnel, a total of 89 people. With the planned actions, compared to its size, the company aims for significant annual savings. QPR issued a profit warning on September 7, 2022,...

The Conference Returns as A Live In-person Event SAN JOSE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature its latest test solutions at the 2022 International Test Conference (ITC), taking place on Sept. 25-30 at the Disneyland Convention Center in Anaheim, California. ITC is the world’s premier conference dedicated to the electronic test of devices, boards and systems, covering the complete cycle from design verification, test, diagnosis, failure analysis and back to process and design improvement. This will be ITC’s first in-person conference since the beginning of the COVID-19 pandemic. Advantest is a proud Platinum sponsor of ITC. Advantest is also a sponsor of IEEE Automotive, Reliability, Test & Safety Workshop (ARTS) and Silicon Lifecycle...

Distinguished Professor Emeritus of Medicine at Indiana University School of Medicine, Chancellor’s Professor at Indiana University Purdue University Indianapolis, and Director of Endoscopy at Indiana University Hospital in IndianapolisBERKELEY, Calif. and MAINZ, Germany, Sept. 20, 2022 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the appointment of Dr. Douglas K. Rex to its Medical Advisory Board (MAB). Dr. Rex is the latest industry expert to join the MAB which was established to support Mainz’s forthcoming U.S. pivotal trial for ColoAlert, the Company’s highly efficacious, and easy-to-use detection test for colorectal cancer (CRC). “As one of the world’s leading experts in the field...

Savosolar Plc Company Announcement             20 September 2022 at 8.30 a.m. (CEST)Savosolar Plc – Managers’ Transaction, Ari Virtanen, September 2022   Person subject to the notification requirementName: Virtanen Ari Tapani  Position: Member of the Board/Deputy member     Initial Notification  Reference number: 19717/4/4     IssuerName: Savosolar OyjLEI: 743700J1YZ8IEJAPDL21     Transaction detailsTransaction date: 2022-09-19Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Nature of the transaction: Subscription Instrument: ShareISIN: FI4000425848 Volume: 6450Unit price: 0.05600 Euro Aggregated transactionsVolume: 6450Volume weighted average price: 0.05600 EuroSAVOSOLAR PLC For more information: Savosolar Plc Managing Director Jari Varjotie Phone: +358 400...

New contract amendment with Public Health Agency of Canada for the supply of IMVAMUNE valued at USD 234 million, with additional options spanning 10 years valued at USD 180 million Under the new contract amendment, the majority of the confirmed order will be delivered in 2023 Furthermore, a multi-year contract valued at up to USD 20 million has been signed with the Canadian Department of National Defence, until 2031COPENHAGEN, Denmark, September 20, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today a revised contract with the Public Health Agency of Canada (PHAC) to supply doses of IMVAMUNE® smallpox vaccine at a value of approximately USD 234 million in addition to USD 180 million in contract options. This extends the USD 56 million contract awarded in June 2022 to a total value of up to USD 470 million. Furthermore, a new multi-year...

Company announcement no. 32 In company announcement no. 9 2022, Spar Nord announced a share buyback programme of up to DKK 225 million. The share buyback was initiated on 15 June 2022. The purpose of the share buyback is to reduce the bank’s share capital by the shares acquired under the programme, and the programme is executed pursuant to Regulation (EU) No 596/2014 of 16 April 2014 (“Market Abuse Regulation”). In week 37, the following transactions were made under the share buyback programme.  Number of shares Average purchase price Transaction value (DKK)Accumulated from last announcement 1,252,000     101,060,61212 September 2022  19,000  90.24  1,714,56013 September 2022  17,000  92.02  1,564,34014 September 2022  16,000  91.19  1,459,04015 September 2022  16,000  92.00  1,472,00016 September 2022  15,000...

SAMPO PLC                 STOCK EXCHANGE RELEASE         20/09/2022 at 08:30 am Sampo plc’s share buybacks 19/09/2022 On 19/09/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  12,447 45.56 AQEU  30,214 45.58 CEUX  6,880 45.60 TQEX  74,398 45.54 XHELTOTAL 123,939 45.56  *rounded to two decimals                 On 9 June 2022, Sampo announced a share buyback programme of up to a maximum of EUR 1 billion in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 10 June 2022, is based...

Geneva, Switzerland, September 20, 2022 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer will present at both the Sachs Associates 22nd Annual Biotech in Europe forum in Basel, Switzerland and the Baader Investment Conference in Munich, Germany taking place September 21 – 22, 2022 and September 23, 2022, respectively. In his presentations, Mr. Dyer will provide a corporate update and discuss recent developments at Addex. A video of each presentation will be available for viewing on-demand by registered participants. Mr. Dyer will also participate in a neurodegenerative diseases roundtable discussion with other panelists at the Sachs Associates Conference, scheduled on September 22, 2022. Mr....

Hepsor N57 OÜ, a subsidiary of Hepsor AS, acquired a property at Nõmme tee 57, Tallinn on 19 August 2022. The construction of the development project located in peaceful and green Kristiine administrative district will begin already in the fourth quarter of 2022. The development project has 26 apartments of different sizes, from compact one-room apartments to spacious four-room apartments with large terraces. Henri Laks, member of the Management Board of Hepsor AS, said: „Over the last year we have added 9 new development projects including 4 in Estonia and 5 in Latvia. Total addition amounts to approximately 430 apartments (incl ca 250 in Estonia and ca 180 in Latvia), which is about 26% of Group’s residential development projects, and approximately 27,700 m2 of commercial property mostly in Latvia. The construction of acquired development...